These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells. Ooi JD; Holdsworth SR; Kitching AR J Autoimmun; 2008 Nov; 31(3):295-300. PubMed ID: 18502098 [TBL] [Abstract][Full Text] [Related]
3. Characterization of a non-Goodpasture autoantibody to type IV collagen. Johansson C; Butkowski R; Swedenborg P; Alm P; Wieslander J Nephrol Dial Transplant; 1993; 8(11):1205-10. PubMed ID: 8302456 [TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease. Borza DB; Hudson BG Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332 [TBL] [Abstract][Full Text] [Related]
5. Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease. Yang R; Cui Z; Hellmark T; Segelmark M; Zhao MH; Wang HY Clin Immunol; 2007 Aug; 124(2):207-12. PubMed ID: 17556023 [TBL] [Abstract][Full Text] [Related]
8. Properties of HLA class II molecules divergently associated with Goodpasture's disease. Phelps RG; Jones V; Turner AN; Rees AJ Int Immunol; 2000 Aug; 12(8):1135-43. PubMed ID: 10917888 [TBL] [Abstract][Full Text] [Related]
10. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen. Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801 [TBL] [Abstract][Full Text] [Related]
11. [Goodpasture's syndrome as an autoimmune disease--identification of the autoantigen]. Cohen AD; Shoenfeld Y Harefuah; 1995 Jan; 128(2):100-4. PubMed ID: 7721170 [No Abstract] [Full Text] [Related]
12. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease. Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY Nephrol Dial Transplant; 2009 Jun; 24(6):1838-44. PubMed ID: 19151145 [TBL] [Abstract][Full Text] [Related]
17. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease. Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850 [TBL] [Abstract][Full Text] [Related]
18. Goodpasture's syndrome: a nursing challenge. Avella P; Walker M Dimens Crit Care Nurs; 1999; 18(2):2-12. PubMed ID: 10640002 [TBL] [Abstract][Full Text] [Related]